We use cookies to offer you a better browsing experience, analyze site traffic, personalize content. Read about how we use Cookies, along with our Privacy Policy and Terms of Use. If you continue to use this site, you consent to our use of cookies.

Clinical trials

ECLIPSE: Lu-177-PSMA-I&T for metastic Castration-Resistant Prostate Cancer

Condition

metastatic Castration-Resistant Prostate Cancer (mCRPC)

ClinicalTrials.gov identifier

NCT

Interventions

Intervention Type: Drug
Intervention Name: Lu-177-PSMA-I&T
Intervention Description: Intravenous radioligand therapy

Curium reference number

CURLu177PSM001

Phase

Phase 3

Protocol Title

Purpose

Contact